Cardiac Masses Discovered by Echocardiogram; What to Do Next?
Reto Kurmann(Mayo Clinic), Kyle W. Klarich(Mayo Clinic), Juan A. Crestanello(Mayo Clinic), Joseph J. Maleszewski(Mayo Clinic), Melanie C. Bois(Mayo Clinic in Arizona), Muhannad Abbasi(WinnMed), Elias Akiki(Carol Davila University of Medicine and Pharmacy), Piotr Mazur(Mayo Clinic in Arizona), Phillip M. Young(Mayo Clinic), Vidhu Anand(Mayo Clinic), Ana I. Casanegra(Mayo Clinic), Ali Ahmad(Mayo Clinic in Arizona), Joerg Herrmann(Mayo Clinic), Edward El‐Am(Mayo Clinic in Arizona)
Cited by 22
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
|Circulation|2015|848
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589